接种Moderna mRNA-1273新冠病毒疫苗后出现的微小病变性肾病。 - Suppr

Suppr

超能文献

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.

作者信息

Holzworth Amy, Couchot Patrick, Cruz-Knight Wanda, Brucculeri Michael

机构信息

Section of Nephrology, Morton Plant Hospital, Clearwater, Florida, USA.

Department of Family Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.

出版信息

Kidney Int. 2021 Aug;100(2):463-464. doi: 10.1016/j.kint.2021.05.007. Epub 2021 May 26.

DOI:10.1016/j.kint.2021.05.007

PMID:34048824

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8149162/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172d/8149162/fab5197a5fe1/gr1_lrg.jpg

相似文献

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.

Kidney Int. 2021 Aug;100(2):463-464. doi: 10.1016/j.kint.2021.05.007. Epub 2021 May 26.

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine.

Kidney Int. 2021 Aug;100(2):457-458. doi: 10.1016/j.kint.2021.04.033. Epub 2021 May 5.

Minimal change disease following the Moderna COVID-19 vaccine: first case report.

BMC Nephrol. 2021 Nov 11;22(1):376. doi: 10.1186/s12882-021-02583-9.

Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.

Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine.

Kidney Int. 2021 Aug;100(2):459. doi: 10.1016/j.kint.2021.06.005. Epub 2021 Jun 10.

Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.

BMJ Case Rep. 2022 Mar 4;15(3):e244638. doi: 10.1136/bcr-2021-244638.

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.

Kidney Int. 2021 Aug;100(2):461-463. doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15.

A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose.

CEN Case Rep. 2022 Nov;11(4):477-481. doi: 10.1007/s13730-022-00702-5. Epub 2022 Apr 18.

Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine.

Dermatol Ther. 2022 Apr;35(4):e15302. doi: 10.1111/dth.15302. Epub 2022 Jan 10.

Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine.

QJM. 2022 Jul 9;115(7):490-491. doi: 10.1093/qjmed/hcac094.

引用本文的文献

Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review.

Front Med (Lausanne). 2025 Jun 9;12:1568943. doi: 10.3389/fmed.2025.1568943. eCollection 2025.

Association of COVID-19 vaccination with relapsed nephrotic syndrome and new onset nephrotic syndrome in children.

Pediatr Nephrol. 2025 Apr 22. doi: 10.1007/s00467-025-06778-2.

Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.

CEN Case Rep. 2025 Jun;14(3):461-467. doi: 10.1007/s13730-025-00967-6. Epub 2025 Feb 17.

Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study.

NPJ Vaccines. 2024 Nov 8;9(1):213. doi: 10.1038/s41541-024-00964-3.

De Novo Biopsy-Proven Glomerular Disease Following COVID-19 Vaccination.

J Clin Med. 2024 Jul 31;13(15):4494. doi: 10.3390/jcm13154494.

Minimal change disease following COVID-19 vaccination: A systematic review.

PLoS One. 2024 Mar 5;19(3):e0297568. doi: 10.1371/journal.pone.0297568. eCollection 2024.

ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.

Front Immunol. 2024 Jan 8;14:1298622. doi: 10.3389/fimmu.2023.1298622. eCollection 2023.

New-onset minimal change disease following the Moderna COVID-19 vaccine.

BMJ Case Rep. 2023 Sep 15;16(9):e255144. doi: 10.1136/bcr-2023-255144.

Nephrotic syndrome following COVID-19 vaccination: a systematic review.

J Nephrol. 2023 Dec;36(9):2431-2440. doi: 10.1007/s40620-023-01710-z. Epub 2023 Jul 28.

Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.

CEN Case Rep. 2024 Feb;13(1):53-58. doi: 10.1007/s13730-023-00798-3. Epub 2023 May 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.

作者信息

Holzworth Amy, Couchot Patrick, Cruz-Knight Wanda, Brucculeri Michael

机构信息

Section of Nephrology, Morton Plant Hospital, Clearwater, Florida, USA.

Department of Family Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.

出版信息

Kidney Int. 2021 Aug;100(2):463-464. doi: 10.1016/j.kint.2021.05.007. Epub 2021 May 26.

DOI:10.1016/j.kint.2021.05.007

PMID:34048824

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8149162/

Abstract

摘要

相似文献

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.

Kidney Int. 2021 Aug;100(2):463-464. doi: 10.1016/j.kint.2021.05.007. Epub 2021 May 26.

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine.

Kidney Int. 2021 Aug;100(2):457-458. doi: 10.1016/j.kint.2021.04.033. Epub 2021 May 5.

Minimal change disease following the Moderna COVID-19 vaccine: first case report.

BMC Nephrol. 2021 Nov 11;22(1):376. doi: 10.1186/s12882-021-02583-9.

Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.

Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine.

Kidney Int. 2021 Aug;100(2):459. doi: 10.1016/j.kint.2021.06.005. Epub 2021 Jun 10.

Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.

BMJ Case Rep. 2022 Mar 4;15(3):e244638. doi: 10.1136/bcr-2021-244638.

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.

Kidney Int. 2021 Aug;100(2):461-463. doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15.

A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose.

CEN Case Rep. 2022 Nov;11(4):477-481. doi: 10.1007/s13730-022-00702-5. Epub 2022 Apr 18.

Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine.

Dermatol Ther. 2022 Apr;35(4):e15302. doi: 10.1111/dth.15302. Epub 2022 Jan 10.

Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine.

QJM. 2022 Jul 9;115(7):490-491. doi: 10.1093/qjmed/hcac094.

引用本文的文献

Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review.

Front Med (Lausanne). 2025 Jun 9;12:1568943. doi: 10.3389/fmed.2025.1568943. eCollection 2025.

Association of COVID-19 vaccination with relapsed nephrotic syndrome and new onset nephrotic syndrome in children.

Pediatr Nephrol. 2025 Apr 22. doi: 10.1007/s00467-025-06778-2.

Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.

CEN Case Rep. 2025 Jun;14(3):461-467. doi: 10.1007/s13730-025-00967-6. Epub 2025 Feb 17.

Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study.

NPJ Vaccines. 2024 Nov 8;9(1):213. doi: 10.1038/s41541-024-00964-3.

De Novo Biopsy-Proven Glomerular Disease Following COVID-19 Vaccination.

J Clin Med. 2024 Jul 31;13(15):4494. doi: 10.3390/jcm13154494.

Minimal change disease following COVID-19 vaccination: A systematic review.

PLoS One. 2024 Mar 5;19(3):e0297568. doi: 10.1371/journal.pone.0297568. eCollection 2024.

ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.

Front Immunol. 2024 Jan 8;14:1298622. doi: 10.3389/fimmu.2023.1298622. eCollection 2023.

New-onset minimal change disease following the Moderna COVID-19 vaccine.

BMJ Case Rep. 2023 Sep 15;16(9):e255144. doi: 10.1136/bcr-2023-255144.

Nephrotic syndrome following COVID-19 vaccination: a systematic review.

J Nephrol. 2023 Dec;36(9):2431-2440. doi: 10.1007/s40620-023-01710-z. Epub 2023 Jul 28.

Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.

CEN Case Rep. 2024 Feb;13(1):53-58. doi: 10.1007/s13730-023-00798-3. Epub 2023 May 27.